Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate

Tumour necrosis factor antagonists and tocilizumab have a higher impact on rheumatoid arthritis osteoclastogenic stimuli than methotrexate

Background Rheumatoid arthritis (RA) is a systemic disease characterised by hyperactivation of the immune system leading to chronic inflammation and joint damage.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2010-03, Vol.69 (Suppl 2), p.A55
Hauptverfasser: Perpétuo, I, Fernandes, D, Cascão, R, Moura, R, Caetano-Lopes, J, Rodrigues, A, Polido-Pereira, J, Viana Queiroz, M, Fonseca, J E, Canhão, H
Format: Artikel
Sprache:eng
Schlagworte:
Cytokines
Gangrene
Immunotherapy
Rheumatoid arthritis
Tumor necrosis factor-TNF
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Rheumatoid arthritis (RA) is a systemic disease characterised by hyperactivation of the immune system leading to chronic inflammation and joint damage.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2010.129643p